Marketing-authorisation holder · United States
Sentynl Theraps Inc
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABSTRAL0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.4MG B · Tablet | Fentanyl | United States | Not marketed | 2011 |
| NULIBRY9.5mg base/vial · Powder | Fosdenopterin | United States | Marketed | 2021 |
| ZOKINVY50mg | 75mg · Capsule | Lonafarnib | United States | Marketed | 2020 |
| ZYCUBO2.9mg/vial · Powder | Copper histidinate | United States | Marketed | 2026 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 4 | 4 | 0 | Companies |